PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release.
about
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivoProteinase-activated receptor-2 mediated inhibition of TNFalpha-stimulated JNK activation - A novel paradigm for G(q/11) linked GPCRsAlternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2.Tissue factor signals airway epithelial basal cell survival via coagulation and protease-activated receptor isoforms 1 and 2House dust mite interactions with airway epithelium: role in allergic airway inflammation.Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages.Proteinase-activated receptor 2 (PAR-2) in gastrointestinal and pancreatic pathophysiology, inflammation and neoplasia.Protease-activated receptors and prostaglandins in inflammatory lung disease.Fungal proteases and their pathophysiological effects.The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.Airway epithelium interactions with aeroallergens: role of secreted cytokines and chemokines in innate immunity.Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis.Effect of PAR-2 Deficiency in Mice on KC Expression after Intratracheal LPS AdministrationPharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis.Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells.Mixed exposure to bacterial lipopolysaccharide and seafood proteases augments inflammatory signalling in an airway epithelial cell model (A549).The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.
P2860
Q24312071-D68BC338-B9B8-4FD4-A11A-AEAA5F9ECB8BQ24318701-6FDC260A-00DB-479F-B3E4-13104BC0DCCAQ30499470-39708EEF-B50E-4EB5-8BEE-858B81C2E616Q30532482-7BFD1A3A-A052-4FEC-ACAA-E60294F266ACQ34339205-7FAD9B28-9E4A-4862-874F-EC9ADD62DA25Q37047991-1B686461-676E-4930-B74F-279849D45DB0Q37351859-889878DF-4F97-4807-A9E0-92D73BA58483Q37447476-BEA4DEC4-6825-4CA9-8200-7729E311D6C9Q37831836-E08513A8-9D2F-4E02-B35D-DC71E36A75A3Q37894093-D8A20C66-AE9F-42A4-BB0D-1F6710DE21C6Q38425485-C2942C44-A92E-43C7-9A7D-106EECDAFFE1Q39024744-F655F402-D9BF-493E-8AC4-9BF773436258Q39734752-4CF60A81-207A-464D-B594-EEAAC39B4552Q43159978-64AC3904-B899-4846-9AE7-12E5A9A85C15Q47154353-2D976190-F60A-46F1-A6A4-3E032083B96DQ51615187-99D3B1C8-466B-440B-AD3D-1C1451455A8AQ55011363-15E66A81-E94A-45BB-A742-2704E00A25C1
P2860
PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
PAR-2 activation and LPS syner ...... vel and interleukin-8 release.
@en
type
label
PAR-2 activation and LPS syner ...... vel and interleukin-8 release.
@en
prefLabel
PAR-2 activation and LPS syner ...... vel and interleukin-8 release.
@en
P2093
P2860
P1476
PAR-2 activation and LPS syner ...... vel and interleukin-8 release.
@en
P2093
Elena Sokolova
Ewa Ostrowska
Georg Reiser
P2860
P304
P356
10.1152/AJPLUNG.00137.2007
P577
2007-08-31T00:00:00Z